China Sxt Pharmaceuticals Stock Today
| SXTC Stock | USD 2.63 0.14 5.05% |
PerformanceInsignificant
| Odds Of DistressHigh
|
China SXT is trading at 2.63 as of the 23rd of March 2025, a 5.05 percent decrease since the beginning of the trading day. The stock's open price was 2.77. China SXT has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Business Domain Household & Personal Products | IPO Date 4th of January 2019 | Category Healthcare | Classification Consumer Staples |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets in China. The company was founded in 2005 and is headquartered in Taizhou, China. The company has 507.8 K outstanding shares of which 37.78 K shares are at this time shorted by private and institutional investors with about 0.28 trading days to cover. More on China SXT Pharmaceuticals
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
China Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman CoCEO | Feng Zhou | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Personal Care Products, Drug Manufacturers - Specialty & Generic, Consumer Staples, NASDAQ Composite, NASDAQ Health Care, Consumer Staples, Personal Care Products, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsChina SXT can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand China SXT's financial leverage. It provides some insight into what part of China SXT's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
China SXT Pharmaceuticals (SXTC) is traded on NASDAQ Exchange in USA. It is located in 178 North Taidong Road, Taizhou, China, 225300 and employs 75 people. China SXT is listed under Personal Care Products category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.34 M. China SXT Pharmaceuticals conducts business under Personal Care Products sector and is part of Consumer Staples industry. The entity has 507.8 K outstanding shares of which 37.78 K shares are at this time shorted by private and institutional investors with about 0.28 trading days to cover.
China SXT Pharmaceuticals currently holds about 15.52 M in cash with (1.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check China SXT Probability Of Bankruptcy
Ownership AllocationChina SXT Pharmaceuticals shows 3.16 percent of its outstanding shares held by insiders and 0.1 percent owned by other corporate entities.
Check China Ownership Details
China Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bank Of Montreal | 2024-12-31 | 10 K | |
| Bmo Capital Markets Corp. | 2024-12-31 | 10 K | |
| Ubs Group Ag | 2024-12-31 | 8.0 | |
| Qube Research & Technologies | 2024-09-30 | 0.0 | |
| Jpmorgan Chase & Co | 2024-12-31 | 0.0 | |
| Gsa Capital Partners Llp | 2024-12-31 | 0.0 | |
| Virtu Financial Llc | 2024-09-30 | 0.0 | |
| Baader Bank Inc | 2024-12-31 | 0.0 | |
| Citadel Advisors Llc | 2024-09-30 | 0.0 |
China SXT Historical Income Statement
China Stock Against Markets
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in China SXT Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China SXT listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.426 | Earnings Share (28.58) | Revenue Per Share | Quarterly Revenue Growth 0.295 | Return On Assets |
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China SXT's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.